SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001193125-15-050914
Filing Date
2015-02-17
Accepted
2015-02-17 21:22:35
Documents
2
Group Members
ESSEX WOODLANDS HEALTH VENTURES VII, L.L.C.ESSEX WOODLANDS HEALTH VENTURES VII, L.P.IMMANUEL THANGARAJJAMES L. CURRIEJEFF HIMAWANMARTIN P. SUTTERPETRI VAINIORONALD EASTMAN

Document Format Files

Seq Description Document Type Size
1 SC 13D d870489dsc13d.htm SC 13D 150277
2 EX-99.1 d870489dex991.htm EX-99.1 13208
  Complete submission text file 0001193125-15-050914.txt   165240
Mailing Address 21 WATERWAY AVENUE SUITE 225 THE WOODLANDS TX 77380
Business Address 21 WATERWAY AVENUE SUITE 225 THE WOODLANDS TX 77380 2813648338
ESSEX WOODLANDS HEALTH VENTURES FUND VII LP (Filed by) CIK: 0001367998 (see all company filings)

IRS No.: 000000000
Type: SC 13D

Mailing Address 235 CONSTITUTION DRIVE MENLO PARK CA 94025
Business Address 235 CONSTITUTION DRIVE MENLO PARK CA 94025 650-298-8012
Corium International, Inc. (Subject) CIK: 0001594337 (see all company filings)

IRS No.: 383230774 | State of Incorp.: DE | Fiscal Year End: 0930
Type: SC 13D | Act: 34 | File No.: 005-88092 | Film No.: 15625830
SIC: 2834 Pharmaceutical Preparations